Presentation

The “Epigenetics and Cell Fate” unit is a multidisciplinary research centre, founded in 2009, and located on the Grands Moulins campus of Université Paris Cité.

The research within the centre focuses on the importance of epigenetic regulations in the determination of cell fate and differentiation programs in mammals, under normal and pathological conditions.

Unit retreat in 2021

© Fabrice Ferron

The unit brings together six teams with complementary expertise in the molecular mechanisms of epigenetics (DNA methylation, histone variants and modifications, and non-coding RNAs), their involvement in development and differentiation processes, and their contribution to pathological processes.

Research in the unit is facilitated daily by a set of technical platforms and support services.

The unit is led by Dr. Slimane AIT-SI-ALI (director) and Dr. Pierre-Antoine DEFOSSEZ (deputy director). Together, they have established a managerial structure allowing the sharing of responsibilities and the delegation of tasks to the senior researchers of the unit. The Management Committee, which includes all the team leaders, makes the strategic decisions. The Lab Council, gathering the team leaders and elected members representing the different categories of personnel, discusses the general decisions concerning the centre’s functioning.

Unit’s organisation chart

Read more

Welcome to Julia

Welcome to Julia

Julia Roche Dupuy joined the lab for her second year Master's internship. Julia Roche Dupuy Second year Master's student À lire aussi

Welcome Caroline to our team!

Welcome Caroline to our team!

We're excited to have Caroline joining Dr. Ait-si-Ali's team! She comes to us as an M2 student from the GENE2 master's program at Université Paris-Saclay. Working with Dr. Guillaume Velasco, Caroline will study the regulation of nuclear stiffness by H3K9...

Welcome Minh to Slimane Ait-si-ali’s team!

Welcome Minh to Slimane Ait-si-ali’s team!

We are delighted to welcome Mynh, an M2 student from the GENE2 master's program at Université Paris-Saclay, to Dr. Ait-si-Ali's team. Mynh will be investigating the role of SETDB1 in Duchenne muscular dystrophy phenotype development.